Ventripoint’s technology is a leading Artificial Intelligence (AI) approach known as Knowledge-Based Reconstruction (KBR), used to create applications to monitor heart disease, a leading cause of death worldwide. The VMS+ is the first cost-effective and accurate AI tool for measuring whole heart function using conventional ultrasound. The Company has developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac care.
(TSXV:VPT, OTCQB:VPTDF)
Company’s Keywords:
cardiovascular imaging, ultrasound, echocardiography, right ventricle, four chambers of the heart, artificial intelligence, 3d, pediatrics, adult congenital, medical device
10
medical devices
4720000
Google Cloud Hosting, Varnish, Mobile Friendly, Wix, DoubleClick, Google Tag Manager, Facebook Login (Connect)
2005